CoChat

Tumor Microenvironment-Modulated Nanozymes for NIR-II-Triggered Hyperthermia-Enhanced Photo-Nanocatalytic Therapy via Disrupting ROS Homeostasis

Open access
Zhu, Lipeng, Dai, Yunlu, Gao, Lizeng, Zhao, Qi · 2021 · International Journal of Nanomedicine

The DOI matches its Crossref record; 51 of the 51 references it cites were found in a registry or an index.

Abstract

Purpose: Reactive oxygen species (ROS) are a group of signaling biomolecules that play important roles in the cell cycle. When intracellular ROS homeostasis is disrupted, it can induce cellular necrosis and apoptosis. It is desirable to effectively cascade-amplifying ROS generation and weaken antioxidant defense for disrupting ROS homeostasis in tumor microenvironment (TME), which has been recognized as a novel and ideal antitumor strategy. Multifunctional nanozymes are highly promising agents for ROS-mediated therapy. Methods: This study constructed a novel theranostic nanoagent based on [email protected] 2-x [email protected] nanozymes (PCCNs) through a facile one-step hydrothermal method. We systematically investigated the photodynamic therapy (PDT)/photothermal therapy (PTT) properties, catalytic therapy (CTT) and glutathione (GSH) depletion activities of PCCNs, antitumor efficacy induced by PCCNs in vitro and in vivo. Results: PCCNs generate singlet oxygen ( 1 O 2 ) with laser (660 nm) irradiation and use catalytic reactions to produce hydroxyl radical (•OH). Moreover, PCCNs show the high photothermal performance under NIR II 1064-nm laser irradiation, which can enhance CTT/PDT efficiencies to increase ROS generation. The properties of O 2 evolution and GSH consumption of PCCNs achieve hypoxia-relieved PDT and destroy cellular antioxidant defense system respectively. The excellent antitumor efficacy in 4T1 tumor-bearing mice of PCCNs is achieved through disrupting ROS homeostasis-involved therapy under the guidance of photothermal/photoacoustic imaging. Conclusion: Our study provides a proof of concept of “all-in-one” nanozymes to eliminate tumors via disrupting ROS homeostasis. Keywords: ROS homeostasis, nanozyme, tumor microenvironment, catalytic therapy, photodynamic/photothermal therapy, photothermal/photoacoustic imaging

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.2147/ijn.s309062

Cites

51 of 51 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 Schematic illustration of disrupting ROS homeostasis mechanism of PCCNs via the cascade-amplifying ROS generation and weakening antioxidant defense.
Figure 1 Schematic illustration of disrupting ROS homeostasis mechanism of PCCNs via the cascade-amplifying ROS generation and weakening antioxidant defense.CC BY-NC · PubMed Central
Figure 2 Synthesis and Characterization of PCCNs. (A) Schematic illustration of the synthesis of multifunctional PCCNs. (B) TEM images of PCCNs. Scale bar: 20 nm. (C) HR-TEM images of PCCNs. Scale bar: 2.5 nm. (D) XRD patterns of PCCNs. (E) EDS characterization of PCCNs. (F) High resolution O 1s in PCCNs. (G) FT-IR spectra of Ce6, PEG-SH, and PCCNs. (H) UV-vis spectrum of Ce6 and PCCNs. (I) TEM of PCCNs dispersed in water, PBS, DMEM, and FBS for 7 days treatment. Scale bar: 50 nm.
Figure 2 Synthesis and Characterization of PCCNs. (A) Schematic illustration of the synthesis of multifunctional PCCNs. (B) TEM images of PCCNs. Scale bar: 20 nm. (C) HR-TEM images of PCCNs. Scale bar: 2.5 nm. (D) XRD patterns of PCCNs. (E) EDS characterization of PCCNs. (F) High resolution O 1s in PCCNs. (G) FT-IR spectra of Ce6, PEG-SH, and PCCNs. (H) UV-vis spectrum of Ce6 and PCCNs. (I) TEM of PCCNs dispersed in water, PBS, DMEM, and FBS for 7 days treatment. Scale bar: 50 nm.CC BY-NC · PubMed Central
Figure 3 (A) The thermographic images of PBS and PCCNs at different intervals under 1064-nm laser (0.9 W cm−2) irradiation. (B) The temperature elevation curves of PCCNs under different concentrations. (C) The temperature elevation curves of PCCNs under different laser power intensities. (D) The temperature variations of PCCNs over four cycles of heating and natural cooling.
Figure 3 (A) The thermographic images of PBS and PCCNs at different intervals under 1064-nm laser (0.9 W cm−2) irradiation. (B) The temperature elevation curves of PCCNs under different concentrations. (C) The temperature elevation curves of PCCNs under different laser power intensities. (D) The temperature variations of PCCNs over four cycles of heating and natural cooling.CC BY-NC · PubMed Central
Figure 4 (A) The fluorescence intensity of DCF in PCCNs using a 660-nm laser under different irradiation time. (B) The fluorescence intensity of DCF from different groups. (C) The FL intensity of DCF in PCCNs using a 660-nm laser under different temperatures.
Figure 4 (A) The fluorescence intensity of DCF in PCCNs using a 660-nm laser under different irradiation time. (B) The fluorescence intensity of DCF from different groups. (C) The FL intensity of DCF in PCCNs using a 660-nm laser under different temperatures.CC BY-NC · PubMed Central
Figure 5 (A) O2 generation of PCCNs with H2O2. (B) GSH depletion under different concentrations of PCCNs.
Figure 5 (A) O2 generation of PCCNs with H2O2. (B) GSH depletion under different concentrations of PCCNs.CC BY-NC · PubMed Central
Figure 6 (A) UV−vis spectra and photographs (inset) of TMB aqueous solution from different groups. (B) UV−vis spectra and photographs (inset) of TMB in PCCNs treated with different H2O2 concentrations. (C) UV−vis spectra and photographs (inset) of TMB aqueous solution from different temperatures. (D) UV−vis spectra and photographs (inset) of TMB in PCCNs solution treated with/without 1064 laser irradiation.
Figure 6 (A) UV−vis spectra and photographs (inset) of TMB aqueous solution from different groups. (B) UV−vis spectra and photographs (inset) of TMB in PCCNs treated with different H2O2 concentrations. (C) UV−vis spectra and photographs (inset) of TMB aqueous solution from different temperatures. (D) UV−vis spectra and photographs (inset) of TMB in PCCNs solution treated with/without 1064 laser irradiation.CC BY-NC · PubMed Central
Figure 7 (A) Cellular internalized amounts of PCCNs under different concentrations and time incubation measured by ICP-MS. (B) Intracellular GSH depletion under different concentrations of PCCNs. (C) Intracellular ROS content was analyzed by flow cytometry after various treatments using DCF as a ROS sensor. (a) represents control group; (b) represents DCF group; (c) represents 660-nm group; (d) represents 1064-nm group; (e) represents PCCNs group; (f) represents H2O2 group; (g) represents PCCNs plus H2O2 group; (h) represents PCCNs plus H2O2 plus 660-nm group; (i) represents PCCNs plus H2O2 plus 660-nm plus 1064-nm group. (D) Quantitative analysis of the fluorescence intensity of intracellular ROS. The differences among groups were calculated using Student’s t-test. Data are presented as the mean ± standard error of the mean. ***p < 0.001.
Figure 7 (A) Cellular internalized amounts of PCCNs under different concentrations and time incubation measured by ICP-MS. (B) Intracellular GSH depletion under different concentrations of PCCNs. (C) Intracellular ROS content was analyzed by flow cytometry after various treatments using DCF as a ROS sensor. (a) represents control group; (b) represents DCF group; (c) represents 660-nm group; (d) represents 1064-nm group; (e) represents PCCNs group; (f) represents H2O2 group; (g) represents PCCNs plus H2O2 group; (h) represents PCCNs plus H2O2 plus 660-nm group; (i) represents PCCNs plus H2O2 plus 660-nm plus 1064-nm group. (D) Quantitative analysis of the fluorescence intensity of intracellular ROS. The differences among groups were calculated using Student’s t-test. Data are presented as the mean ± standard error of the mean. ***p < 0.001.CC BY-NC · PubMed Central
Figure 8 (A) Relative viability of HUVECs and 4T1 cells with different concentrations of PCCNs for 24 h. (B) Cell survival rate of the synergistic comprehensive treatment effects of PCCNs by the CCK-8 assay. (C) Fluorescence images of 4T1 cells after various treatments and the cells were co-stained with calcein-AM (green, living cells) and propidium iodide (red, dead cells). Scale bars represent 100 µm. The differences among groups were calculated using Student’s t-test. Data are presented as the mean ± standard error of the mean. *p < 0.05, **p < 0.01.
Figure 8 (A) Relative viability of HUVECs and 4T1 cells with different concentrations of PCCNs for 24 h. (B) Cell survival rate of the synergistic comprehensive treatment effects of PCCNs by the CCK-8 assay. (C) Fluorescence images of 4T1 cells after various treatments and the cells were co-stained with calcein-AM (green, living cells) and propidium iodide (red, dead cells). Scale bars represent 100 µm. The differences among groups were calculated using Student’s t-test. Data are presented as the mean ± standard error of the mean. *p < 0.05, **p < 0.01.CC BY-NC · PubMed Central
Figure 9 In vivo tumor dual-modal imaging. Photoacoustic imaging (A) and averaged PAI intensity (B) of the tumor-bearing mce intravenously injected with PCCNs at 0, 3, 6, 12, and 24 h, respectively. The PTT images (C) and temperature elevation curves (D) of tumor-bearing mice measured after intravenous injection of PBS and PCCNs plus further laser irradiation. The differences among groups were calculated using Student’s t-test. Data are presented as the mean ± standard error of the mean. ***p < 0.001.
Figure 9 In vivo tumor dual-modal imaging. Photoacoustic imaging (A) and averaged PAI intensity (B) of the tumor-bearing mce intravenously injected with PCCNs at 0, 3, 6, 12, and 24 h, respectively. The PTT images (C) and temperature elevation curves (D) of tumor-bearing mice measured after intravenous injection of PBS and PCCNs plus further laser irradiation. The differences among groups were calculated using Student’s t-test. Data are presented as the mean ± standard error of the mean. ***p < 0.001.CC BY-NC · PubMed Central
Figure 10 In vivo synergistic therapy. (A) Tumor volume curve of mice treated with (1) PBS, (2) PCCNs, (3) PCCNs plus 660-nm laser, (4) PCCNs plus 1064-nm laser, and (5) PCCNs plus 660- plus 1064-nm laser. (B) The digital photographs of tumors from different groups after different treatments. (C) Survival rates of mice after different treatments. The GSH depletion (D) in tumor tissues and HIF-1α (E) stained tumor slides after PCCNs treatment. H&E (F) and TUNEL (G) staining tumor slides after different treatments. Scale bar: 100 μm. The differences among groups were calculated using Student’s t-test. Data are presented as the mean ± standard error of the mean. **p < 0.01, ***p < 0.001.
Figure 10 In vivo synergistic therapy. (A) Tumor volume curve of mice treated with (1) PBS, (2) PCCNs, (3) PCCNs plus 660-nm laser, (4) PCCNs plus 1064-nm laser, and (5) PCCNs plus 660- plus 1064-nm laser. (B) The digital photographs of tumors from different groups after different treatments. (C) Survival rates of mice after different treatments. The GSH depletion (D) in tumor tissues and HIF-1α (E) stained tumor slides after PCCNs treatment. H&E (F) and TUNEL (G) staining tumor slides after different treatments. Scale bar: 100 μm. The differences among groups were calculated using Student’s t-test. Data are presented as the mean ± standard error of the mean. **p < 0.01, ***p < 0.001.CC BY-NC · PubMed Central
Figure 11 The in vivo biosafety evaluation. (A) Body weight curve of mice treated with (a) PBS, (b) PCCNs, (c) PCCNs plus 660-nm laser, (d) PCCNs plus 1064-nm laser, and (e) PCCNs plus 660- plus 1064-nm laser. (B) H&E-stained images of heart, liver, spleen, lung, and kidney of the mice treated with PBS and PCCNs. Scale bar stands for 100 μm. Serum levels of ALT (C) and AST (D) from different groups after different treatments.
Figure 11 The in vivo biosafety evaluation. (A) Body weight curve of mice treated with (a) PBS, (b) PCCNs, (c) PCCNs plus 660-nm laser, (d) PCCNs plus 1064-nm laser, and (e) PCCNs plus 660- plus 1064-nm laser. (B) H&E-stained images of heart, liver, spleen, lung, and kidney of the mice treated with PBS and PCCNs. Scale bar stands for 100 μm. Serum levels of ALT (C) and AST (D) from different groups after different treatments.CC BY-NC · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 51 references

Cited by

Metadata

Authors
Zhu, L., Dai, Y., Gao, L., & Zhao, Q.
Affiliations
  • University of Macau (MO)
  • Chinese Academy of Sciences (CN)
Corresponding author
Zhao, Qi
Venue
International Journal of Nanomedicine
Published
2021-07
Volume
Volume 16
Pages
4559-4577
ISSN
  • 1176-9114 (ISSN-L)
  • 1178-2013
OpenAlex
W3181422550
Cited by
27
References
51
Citations by year
2026: 3 · 2025: 2 · 2024: 5 · 2023: 7 · 2022: 9 · 2021: 1
FWCI
1.67
Type
journal article
Language
en
Open access
Locations
  • International Journal of Nanomedicine (publishedVersion, cc-by-nc)
  • PubMed Central (publishedVersion, cc-by-nc)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
  • Dove Medical Press (Taylor and Francis Group) (submittedVersion, other-oa)
Funders
  • Universidade de Macau (SRG2016-00082-FHS, MYRG2019‐00069‐FHS)
  • Fundo para o Desenvolvimento das Ciências e da Tecnologia (FDCT/0015/2918/A1, FDCT/131/2016A3)
Topics
  • Physical Sciences › Engineering › Biomedical Engineering › Nanoplatforms for cancer theranostics
  • Physical Sciences › Materials Science › Materials Chemistry › Advanced Nanomaterials in Catalysis
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Photodynamic Therapy Research Studies
Keywords
nanozymes, reactive oxygen species homeostasis, tumor microenvironment, NIR-II photothermal therapy, photodynamic therapy, catalytic therapy, glutathione depletion, singlet oxygen, hydroxyl radicals, oxygen evolution reaction, antioxidant defense, 4T1 breast cancer, antitumor efficacy
MeSH terms
Animals, Catalysis, Cerium, Copper, Glutathione, Homeostasis, Humans, Hyperthermia, Induced, Infrared Rays, Photochemotherapy, Polyethylene Glycols, Sulfides, Reactive Oxygen Species, Cell Line, Tumor, Nanomedicine, Mice, Tumor Microenvironment

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.